2-(2-Methoxyethoxy)ethanol
Common Name: |
2-(2-Methoxyethoxy)ethanol |
IUPAC Name: |
2-(2-methoxyethoxy)ethanol |
Molecular Formula: |
C5H12O3 |
SMILES: |
COCCOCCO |
Inchi: |
1S/C5H12O3/c1-7-4-5-8-3-2-6/h6H,2-5H2,1H3 |
Inchi Key: |
SBASXUCJHJRPEV-UHFFFAOYSA-N |
Cas No: |
111-77-3 |
Name |
Value |
Lipinski Violations |
0 |
Ghose Violations |
2 |
Veber Violations |
0 |
Egan Violations |
0 |
Muegge Violations |
1 |
Name |
Value |
Molecular Weight (g/mol) |
120.15 |
Mass (g/mol) |
120.079 |
Molar Refractivity |
29.48 |
Net Charge |
|
HBD |
1 |
HBA |
3 |
Rt Bonds |
5 |
Rings |
|
TPSA |
38.69 |
Hetero Atoms |
3 |
Heavy Atoms |
8 |
Aromatic Heavy Atoms |
0 |
Melting Point (°C) |
-70 |
Boiling Point (°C@760.00mm Hg) |
191.00 to 198.00 |
Vapor Pressure (mmHg@25.00 °C) |
0.118 |
Vapor Density (Air =1) |
4.14 |
Fraction Csp3 |
1.00 |
LogP |
-0.358 |
iLOGP |
1.68 |
XLOGP3 |
-0.91 |
WLOGP |
-0.36 |
MLOGP |
-0.65 |
ESOL Log S |
0.32 |
ESOL Solubility (mg/ml) |
250 |
ESOL Solubility (mol/l) |
2.08 |
ESOL Class: esol_class |
Highly soluble |
Ali Log S |
0.58 |
Ali Solubility (mg/ml) |
457 |
Ali Solubility (mol/l) |
3.81 |
Ali Class |
Highly soluble |
Silicos-IT LogSw |
-0.74 |
Silicos-IT Solubility (mg/ml) |
21.7 |
Silicos-IT Solubility (mol/l) |
0.18 |
Silicos-IT Class |
Soluble |
Name |
Value |
GI Absorption |
High |
BBB Permeable |
0 |
PgP Substrate |
0 |
Log Kp (cm/s) |
-7.68 |
Bioavailability Score |
0.55 |
Caco2 |
1 |
Human Intestinal Absorption |
1 |
Plasm Protein Binding |
0.635 |
CYP1A2 Inhibitor |
0 |
CYP2C19 Inhibitor |
0 |
CYP2C9 Inhibitor |
0 |
CYP2D6 inhibitor |
0 |
CYP3A4 inhibitor |
0 |
Ames mutagenesis |
0 |
Acute Oral Toxicity |
1.874 |
Carcinogenicity (Binary) |
0 |
Carcinogenicity (Trinary) |
Non-required |
Eye Irritation |
1 |
Hepatotoxicity |
0 |
Androgen Receptor Binding |
0 |
Aromatase Binding |
0 |
Estrogen Receptor Binding |
0 |
Glucocorticoid Receptor Binding |
0 |
Thyroid Receptor Binding |
0 |
BRCP inhibitor |
0 |
BSEP inhibitor |
0 |
OATP1B1 inhibitor |
1 |
OATP1B3 inhibitor |
1 |
OATP2B1 inhibitor |
0 |
OCT1 inhibitor |
0 |
OCT2 inhibitor |
0 |